EuroHePP : The European Toolkit to Strengthen National Responses for the Elimination of Viral Hepatitis in Prisons

People living in prison are disproportionately affected by hepatitis B and C, yet access to prevention, testing, and treatment services remains inconsistent across Europe. Addressing this gap is critical to achieving viral hepatitis elimination targets by 2030. EuroHePP is a European toolkit developed to support national responses to viral hepatitis in prison settings. It was created through a structured, multi-stage process involving evidence review, stakeholder consultations, and expert validation. The toolkit provides practical guidance across the full continuum of care, including prevention, testing, treatment, and monitoring, and promotes micro-elimination approaches tailored to prison populations. It emphasises evidence-based interventions such as opt-out testing, decentralised and simplified models of care, harm reduction strategies, and continuity of care after release. By offering adaptable tools and frameworks for policymakers and practitioners, EuroHePP aims to strengthen prison health systems, reduce health inequalities, and accelerate progress towards hepatitis elimination at national and regional levels.

Authors

Institutions

Publication Details

Journal
Liver International
Published
2026-09-15
DOI
https://doi.org/10.1111/liv.70874
Primary Topic
Hepatitis C virus research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
article

EuroHePP : The European Toolkit to Strengthen National Responses for the Elimination of Viral Hepatitis in Prisons

Carole Seguin‐Devaux, Linda Montanari, Fadi Meroueh, Roberto Ranieri et al.
Liver International
Hepatitis C virus research
article

EuroHePP : The European Toolkit to Strengthen National Responses for the Elimination of Viral Hepatitis in Prisons

Carole Seguin‐Devaux, Linda Montanari, Fadi Meroueh, Roberto Ranieri, Joaquín Cabezas, Filipa Alves da Costa, Christian Brixko, Serena Fondelli, Nicola Cocco, Lara Tavoschi, Arkadiusz Komorowski, Thomas Seyler, Guglielmo Arzilli, Rafaela Rigoni, Olivia Dawson, Alessio Saponaro, Sara Mazzilli, María Buti, Ehab Salah, Heino Stöver, Éamonn O'Moore, Erika Duffell, Charlotte Deogan, Gabriele Fischer
article en

Abstract

People living in prison are disproportionately affected by hepatitis B and C, yet access to prevention, testing, and treatment services remains inconsistent across Europe. Addressing this gap is critical to achieving viral hepatitis elimination targets by 2030. EuroHePP is a European toolkit developed to support national responses to viral hepatitis in prison settings. It was created through a structured, multi-stage process involving evidence review, stakeholder consultations, and expert validation. The toolkit provides practical guidance across the full continuum of care, including prevention, testing, treatment, and monitoring, and promotes micro-elimination approaches tailored to prison populations. It emphasises evidence-based interventions such as opt-out testing, decentralised and simplified models of care, harm reduction strategies, and continuity of care after release. By offering adaptable tools and frameworks for policymakers and practitioners, EuroHePP aims to strengthen prison health systems, reduce health inequalities, and accelerate progress towards hepatitis elimination at national and regional levels.

Liver InternationalVol. 46(10)
University of Pisa (IT), Goethe University Frankfurt (DE), AOL (United States) (US), European Union (BE), University of Lisbon (PT), HM Prison Service (GB), United Nations Office on Drugs and Crime (AT), Health Service Executive (IE), Directorate of Health (IS), Service de la Santé Publique (CH), World Health Organization Regional Office for Europe (DK), Marqués de Valdecilla University Hospital (ES), Luxembourg Institute of Health (LU), Tarımsal Araştırmalar ve Politikalar Genel Müdürlüğü (TR), Instituto de Investigación Marqués de Valdecilla (ES), Vall d'Hebron Hospital Universitari (ES), Harm Reduction Services (US), International University in Geneva (CH), Centre hospitalier régional de la Citadelle (BE), Austrian Political Science Association (AT), Frankfurt University of Applied Sciences (DE), European Centre for Disease Prevention and Control (SE), Medical University of Vienna (AT)
European Centre for Disease Prevention and Control, Università di Pisa
Reduced inequalities
Openalex Percentile: Top 13%
Hepatitis C virus research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.